About
Stem Cell Regenerative Medicine
Areas of Focus
Categories
Biologics & BiopharmaceuticalStem Cell & Cellular TherapyAntibodyJapan
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
14
As Collaborator
2
Total Enrollment
1,637
By Phase
PHASE2: 6PHASE2/PHASE3: 2NA: 3PHASE3: 1PHASE1/PHASE2: 1PHASE1: 3
By Status
COMPLETED: 9UNKNOWN: 3TERMINATED: 2RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04533464Lead Sponsor
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
PHASE2Recruiting
156 participants
Started: Nov 9, 2020 · Completed: Dec 31, 2025
NCT04367077Lead Sponsor
MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)
PHASE2/PHASE3Unknown
400 participants
Started: Apr 28, 2020 · Completed: Dec 31, 2023
NCT03908983Lead Sponsor
OPtimisation of Surgical Repair for Treating Insufficiency of the MItral Valve - Safety and Effectiveness Evaluation
NAUnknown
100 participants
Started: Nov 20, 2019 · Completed: May 31, 2025
NCT03807804Lead Sponsor
Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome
PHASE2Completed
35 participants
Started: Jan 1, 2019 · Completed: Dec 14, 2021
NCT03545607Lead Sponsor
MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study
PHASE3Unknown
300 participants
Started: Jul 28, 2018 · Completed: Jun 30, 2023
Locations (1)
Headquarters
Tokyo, Japan
Map
Loading map...